Neuro-Oncology

Media spotlight potential treatment breakthrough for advanced brain cancer

Posted on June 2, 2016

U.S. News and World Report and Ars Technica June 1, and Tech Times and Relia Wire June 2 reported on the development of a treatment for people with recurrent brain cancers including glioblastoma, the most common and aggressive form. Researchers successfully demonstrated that a modified virus combined with an antifungal medication can extend the lives of patients with this deadly disease. Dr. Timothy Cloughesy, lead author of the study and member of UCLA’s Jonsson Comprehensive Cancer Center and director of the UCLA Neuro-Oncology Program, was quoted.